Processing of exogenous protein antigen by murine dendritic cells for presentation to cytotoxic T lymphocytes

Advances in Experimental Medicine and Biology

Volumn 417, Issue , 1997, Pages 213-220

  De Bruijn, Marloes L H ^a   Schuurhuis, Danita H ^a   Vermeulen, Hans ^a   De Cock, Karin A J ^a   Melief, Cornelis J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; CANCER IMMUNOTHERAPY; CELL MATURATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; LANGERHANS CELL; PHENOTYPE; PRIORITY JOURNAL;

MURINAE;

EID: 0030832171     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9966-8_36     Document Type: Conference Paper

References (34)

1. Inaba, K., Young, J.W. and Steinman, R.M., 1987, Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells, J. Exp. Med. 166: 182.
2. Macatonia, S.E., Taylor, P.M., Knight, S.C. and Askonas, B.A., 1989, Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro, J. Exp. Med. 169:1255.
3. De Bruijn, M.L.H., Nieland, J.D., Schumacher, T.N.M., Ploegh, H.L., Kast, W. Martin and Melief, C.J.M., 1992, Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses, Eur. J. Immunol. 22:3013.
4. Schuler, G. and Steinman, R.M., 1985, Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 172: 383.
5. Romani, N., Koide, S., Crowley, M., Witmer-Pack, M., Livingstone, A.M., Fathman, C.G., Inaba, K. and Steinman, R.M., 1989, Presentation of exogenous protein antigen by dendritic cells to T cell clones. Intact protein is presented best by immature epidermal Langerhans cells, J. Exp. Med. 169: 1169.
6. Streilein, J.W. and Grammer, S.F., 1989, In vitro evidence that Langerhans cells can adopt two functionally distinct forms of antigen presentation to T lymphocytes, J Immunol. 143: 3925.
7. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R.M., 1992, Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor, J. Exp. Med. 176:1693.
8. Inaba, K., Steinman, R.M., Witmer Pack, M., Aya, H., Inaba, M., Sudo, T., Wolpe, S. and Schuler, G., 1992, Identification of proliferating dendritic cell precursors in mouse blood, J. Exp. Med. 175: 1157.
9. Scheicher, C., Mehlig, M., Zecher, R. and Reske, K., 1992, Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-stimulating factor, J. Immunol. Methods 154:253.
10. Reid, C.D., Stackpoole, A., Meager, A. and Tikerpae, J., 1992, Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow, J. Immunol. 149: 2681.
11. Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch P.O., Steinman, R.M. and Schuler, G., 1994, Proliferating dendritic cell progenitors in human blood, J. Exp. Med. 180:83.
12. Sallusto, F. and Lanzavecchia, A., 1994, Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alfa, J. Exp. Med. 179: 1109.
13. Girolomoni, G., Simon, J.C., Bergstresser, P.R. and Cruz, P.D. Jr., 1990, Freshly isolated spleen dendritic cells and epidermal Langerhans cells undergo similar phenotypic and functional changes during short term culture, J. Immunol. 145: 2820.
14. Austyn, J.M., 1992, Antigen uptake and presentation by dendritic leukocytes, Semin. Immunol. 4:227.
15. Nijman, H.W., Kleijmeer, M.J., Ossevoort, M.A., Oorschot V.M.J., Vierboom, M.P.M., van de Keur, M., Kenemans, P., Kast, W.M., Geuze, H.J. and Melief, C.J.M., 1995, Antigen capture and MHC class II compartments of freshly isolated and cultured human blood dendritic cells, J. Exp. Med. 182: 163.
16. Aiba, S. and Katz, S.I., 1991, The ability of cultured Langerhans cell to process and present protein antigens is MHC-dependent, J. Immunol. 146: 2479.
17. De Bruijn, M.L.H., Nieland, J.D., Harding, C.V. and Melief, C.J.M., 1992, Processing and presentation of intact hen egg-white lysozyme by dendritic cells, Eur. J. Immunol. 22: 2347.
18. Bender, A., Kim Bui, L., Feldman, M.A.V, Larsson, M. and Bhardwaj, N., 1995, Inactivated Influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses, J. Exp. Med. 182: 1663.
19. Pfeifer, J.D., Wick, M.J., Roberts, R.L., Findlay, K., Normark, S.J. and Harding, C.V., 1993, Phagocytic processing of bacterial antigens for class I MHC presentation to T cells, Nature 361:359.
20. Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B. and Rock, K.L., 1993, Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages, Proc. Natl. Acad. Sci. USA 90:4942.
21. Harding, C.V. and Song, R., 1994, Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules, J. Immunol. 153:4925.
22. De Bruijn, M.L.H., Jackson, M.R. and Peterson, P.A., 1995, Phagocyte-induced antigen-specific activation of unprimed CD8+ T cells in vitro, Eur. J. Immunol. 25: 1274.
23. Reis e Sousa, C., Stahl, P.D. and Austyn, J.M., 1993, Phagocytosis of antigens by Langerhans cells in vitro, J. Exp. Med. 178:509.
24. Inaba K., Inaba., M., Saito, M. and Steinman, R.M., 1993, Dendritic cells progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo, J. Exp. Med. 178:479.
25. Austyn., J., 1996. New insights into mobilization and phagocytic activity of dendritic cells, J. Exp. Med. 183: 1287.
26. Ossevoort, M.A., Feltkamp, M.C., van Veen, K.J., Melief, C.J.M. and Kast, W.M., 1995, Dendritic cells as carriers for a CTL epitope-based peptide vaccin in protection against a HPV16-induced tumor, J. Immunotherapy 18:86.
27. Celluzzi, C.M., Mayordomo, J.I., Storkus, W.J., Lotze, M.T. and Falo, L.D. Jr., 1996, Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity, J. Exp. Med. 183: 283.
28. Porgador, A., Snyder, D., and Gilboa, E., 1996, Induction of antitumor immunity using bone marrow-generated dendritic cells, J. Immunol. 156: 2918.
29. Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Celluzi, C., Falo, L.D., Melief, C.J.M, Ildstad, S.T., Kast, W.M., DeLeo, A.B. and Lotze, M.T., 1995, Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity, Nature Medicine 1: 1297.
30. Mayordomo, J.I., Loftus, D.J., Sakamoto, H., De Cesare, C.M., Appasamy, P.M., Lotze, M.T., Storkus, W.J., Appella, E. and DeLeo A.B., 1996, Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines, J. Exp. Med. 183:1357.
31. Zitvogel L., Mayordomo, J.I., Tjandrawan, T., DeLeo, A.B., Clarke, M.R., Lotze, M.T. and Storkus, W.J., 1996, Therapy of murine tumors with tumor peptide pulsed dendritic cells: dependence on T cells, B7 costimulation, and Th1-associated cytokines, J.Exp. Med. 183: 87.
32. Hsu, F.J., Benike, C., Fagnoni, F., Liles, T.M., Czerwinski D., Taidi, B., Engelman, E.G. and Levy, R., 1996, Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells, Nature Medicine 2: 52
33. Inaba, K., Metlay, J.P., Crowley, M.T. and Steinman, R.M., 1990, Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ, J. Exp. Med. 172: 631.
34. Paglia, P., Chiodoni, C., Rodolfo, M.. and Colombo, M.P., 1996. Murine dendritic cells loaded in vitro with soluble protein prime CTL against tumor antigen in vivo, J. Exp. Med. 183: 317.